# Nuclide record paper-propsma-hofman-lancet-2020 (paper). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/key-papers/paper-propsma-hofman-lancet-2020/>
  a schema:ScholarlyArticle ;
  nuclide:kind "paper" ;
  schema:identifier "paper-propsma-hofman-lancet-2020" ;
  schema:name "proPSMA: PSMA PET-CT versus conventional imaging for staging high-risk prostate cancer"@en ;
  schema:description "PSMA PET-CT was 27 percentage points more accurate than CT and bone scan for finding spread in men with high-risk prostate cancer before treatment, with less radiation and more influence on management, and it has replaced conventional imaging where available."@en ;
  schema:url <https://nuclide.cc/key-papers/paper-propsma-hofman-lancet-2020/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S0140-6736(20)30314-7>, <https://pubmed.ncbi.nlm.nih.gov/32209449/> ;
  schema:sameAs <https://doi.org/10.1016/S0140-6736(20)30314-7> ;
  schema:datePublished "2020"^^xsd:gYear ;
  schema:author "Hofman MS, Lawrentschuk N, Francis RJ, et al." ;
  nuclide:related <https://nuclide.cc/isotopes/ga-68/> ;
  nuclide:indications <https://nuclide.cc/indications/prostate-bcr/>, <https://nuclide.cc/indications/prostate-high-risk/> ;
  nuclide:trials <https://nuclide.cc/trials/propsma/> ;
  nuclide:journals <https://nuclide.cc/journals/lancet/> .